tft
known
concentr
herp
simplex
viru
hsv
infect
cell
vitro
form
phosphoryl
deriv
studi
murin
hepat
model
hsv
infect
determin
whether
vitro
observ
would
also
demonstr
vivo
follow
iv
inject
mgkg
tft
tfi
found
significantli
higher
concentr
liver
infect
mice
liver
uninfect
mice
mice
infect
murin
hepat
viru
mice
hepat
carbon
tetrachlorid
treatment
neither
alter
renal
function
alter
pharmacokinet
could
account
differ
nuclear
magnet
reson
spectroscopi
readili
detect
tft
liver
extract
whole
liver
particularli
higher
tissu
level
ie
kgg
tissu
studi
live
anim
support
preliminari
observ
clinic
applic
could
pursu
summari
trifluorothymidin
tft
known
concentr
herp
simplex
viru
hsv
infect
cell
vitro
form
phosphoryl
deriv
studi
murin
hepat
model
hsv
infect
determin
whether
vitro
observ
would
also
demonstr
vivo
follow
iv
inject
mgkg
tft
tfi
found
significantli
higher
concentr
liver
infect
mice
liver
uninfect
mice
mice
infect
murin
hepat
viru
mice
hepat
carbon
tetrachlorid
treatment
neither
alter
renal
function
alter
pharmacokinet
could
account
differ
nuclear
magnet
reson
spectroscopi
readili
detect
tft
liver
extract
whole
liver
particularli
higher
tissu
level
ie
kgg
tissu
studi
live
anim
support
preliminari
observ
clinic
applic
could
pursu
herp
simplex
viru
herp
simplex
hepat
nuclear
magnet
reson
carbon
tetrachlorid
hepat
introduct
number
antivir
drug
exhibit
mark
accumul
herp
simplex
viru
hsv
infect
cell
vitro
viru
induc
enzym
thymidin
kinas
tk
phosphoryl
drug
monophosph
convert
diand
triphosph
cellular
enzym
mechan
shown
lead
intracellular
accumul
phosphoryl
deriv
acyclovir
furman
guanin
dhpg
smee
trifluorothymidin
tft
fischer
agent
price
tft
contain
fluorin
atom
compris
approxim
molecular
weight
sinc
natur
occur
isotop
f
nuclear
spin
possibl
suffici
concentr
tft
could
detect
nuclear
magnet
reson
nmr
spectroscopi
could
shown
tft
concentr
vivo
tissu
infect
anim
vitro
possibl
excess
accumul
could
detect
noninvas
f
nmr
spectroscopi
tft
cross
blood
brain
barrier
poorli
measur
tft
concentr
liver
mice
hepat
due
comparison
tft
level
measur
liver
uninfect
mice
mice
infect
coronaviru
mice
carbon
tetrachlorid
ccl
induc
hepat
strain
kindli
suppli
dr
n
balachandran
colleg
veterinari
medicin
univers
florida
gainesvil
fl
grown
titer
vero
cell
previous
describ
rand
mhv
kindli
suppli
dr
katherin
holm
grown
cell
describ
elsewher
holm
follow
strain
mice
obtain
nation
cancer
institut
balbc
cbaj
ahen
aj
pn
preliminari
studi
show
cbaj
strain
consist
yield
highest
titer
liver
follow
intraperiton
infect
strain
studi
therefor
done
cbaj
mice
age
wk
weigh
g
obtain
depart
patholog
univers
florida
gainesvil
fl
jackson
laboratori
bar
harbor
purchas
sigma
st
loui
mo
carbon
tetrachlorid
obtain
fisher
springfield
nj
dissolv
oliv
oil
pompeiian
baltimor
md
inject
tft
assay
high
pressur
liquid
chromatographi
hplc
method
previous
describ
rand
four
six
week
old
g
cbaj
mice
inject
intraperiton
ip
ml
x
pfuml
mhv
pfuml
model
maxim
titer
present
liver
day
mice
gener
die
day
high
inoculum
titer
hvm
also
maxim
day
mice
less
ill
infect
three
day
infect
mice
anesthet
mixtur
mgiml
ketamin
mgml
xylazin
dose
mlkg
jugular
vein
surgic
expos
mice
inject
intraven
mgikg
tfi
appropri
volum
mgml
solut
phosphat
buffer
salin
pb
ph
chose
jugular
venou
inject
could
assur
accuraci
intraven
inject
mice
sacrif
min
h
iv
inject
tft
liver
immedi
excis
frozen
could
studi
viral
titrat
measur
tit
ml
pb
mix
g
liver
mixtur
homogen
stroke
use
pyrex
ten
broeck
tissu
grinder
follow
sonic
x
fisher
sonic
dismembr
rel
output
ml
liver
homogen
mix
equal
volum
methanol
vortex
extens
centrifug
x
g
min
supernat
analyz
hplc
tfi
result
express
per
gram
liver
correct
dilut
prior
sonic
ml
liver
homogen
serial
dilut
serum
free
tissu
cultur
media
titrat
triplic
vero
cell
previous
describ
rand
experi
clarifi
supernat
mix
methanol
describ
place
mm
nmr
tube
content
measur
nmr
spectroscopi
see
experi
entir
liver
excis
place
mm
nmr
tube
directli
analyz
nmr
spectroscopi
describ
carbon
tetrachlorid
select
control
hepat
previou
work
suggest
dose
relat
hepat
toxic
limit
liver
involv
kidney
might
conceiv
alter
pharmacokinet
tft
watrou
plaa
klassen
diaz
gomez
ccl
induc
dose
depend
patchi
centrilobular
necrosi
analog
induc
hsv
infect
liver
goodman
prior
ip
inject
ccl
oliv
oil
ml
blood
collect
group
mice
twentyfour
hour
ip
inject
mlkg
cc
oliv
oil
blood
collect
set
analyz
alanin
amino
transferas
alt
blood
urea
nitrogen
bun
alt
serum
analyz
duplic
technicon
ra
bun
duplic
sampl
analyz
beckman
astra
mice
sacrif
cervic
disloc
liver
kidney
fix
formalin
stain
hematoxylin
eosin
examin
histolog
assay
carri
nicoletg
nmr
spectromet
use
standard
techniqu
simpl
onepuls
sequenc
field
tesla
frequenc
mhz
depend
upon
volum
sampl
avail
place
either
mm
mm
diamet
tube
usual
spun
whole
liver
liver
homogen
place
ml
l
vv
mixtur
methanol
inactiv
hsv
permit
field
homogen
optim
provid
fieldfrequ
lock
time
averag
cycl
time
use
tip
angl
sweep
width
hz
data
point
collect
concentr
sampl
evalu
compar
electron
integr
area
reson
peak
applic
hz
line
broaden
fourier
transform
free
induct
delay
use
comput
standard
contain
kgml
instrument
reproduc
calcul
area
check
compar
integr
ugml
standard
calcul
scale
set
obtain
kgml
standard
calcul
tft
concentr
appropri
allow
made
dilut
sampl
size
organ
sampl
tube
well
tfi
extract
organ
surround
medium
wide
variat
tft
level
relationship
viral
titer
pfuig
liver
could
assum
tft
level
normal
distribut
among
hsv
infect
mice
therefor
data
analyz
nonparametr
mannwhitney
u
test
tabl
show
result
repres
experi
tft
level
viral
titer
measur
liver
infect
uninfect
wk
old
cbaj
mice
infect
mice
tft
mean
se
pgg
liver
compar
kgg
liver
uninfect
mice
p
mannwhitney
u
dose
mlkg
cc
oliv
oil
inject
ip
overwhelm
hepat
necrosi
result
day
later
alt
level
blood
rang
wml
see
tabl
shown
bun
signific
alter
renal
function
histolog
dose
relat
centrilobular
necrosi
mlkg
massiv
mlkg
local
less
extens
preliminari
experi
carri
determin
averag
alt
level
infect
mice
day
time
higher
level
tft
found
liver
day
follow
ip
inject
x
pfu
mice
alt
mean
sd
iuiml
blood
dose
respons
curv
ccl
hepat
show
mlkg
would
lead
alt
level
iuml
blood
h
later
therefor
ccl
use
dose
mlkg
despit
preliminari
data
alt
level
measur
blood
cc
treat
mice
actual
given
tft
tabl
fig
show
essenti
differ
blood
level
tft
min
iv
inject
measur
blood
level
tft
h
among
group
infect
mice
significantli
higher
level
tft
liver
h
iv
inject
tft
whether
compar
uninfect
ccl
treat
mice
tft
level
liver
due
accumul
hsv
infect
liver
cell
higher
hsv
titerg
liver
higher
tft
level
relationship
pfug
liver
tft
concentrationg
liver
among
infect
mice
illustr
separ
experi
fig
first
experi
show
relationship
titer
pfuig
liver
tft
concentrationg
liver
infect
mice
studi
h
iv
inject
tft
shown
fig
linear
regress
show
correl
coeffici
r
p
experi
r
p
similar
relationship
also
observ
among
infect
mice
studi
h
receiv
blood
urea
nitrogen
serum
alanin
aminotransferas
level
carbon
tetrachlorid
herp
simplex
treat
cbaj
mice
tft
well
receiv
higher
dose
mgkg
tfi
shown
tabl
separ
experi
tft
level
hsv
titer
measur
use
small
portion
liver
leav
approxim
g
intact
micegroup
measur
level
nmr
spectroscopi
condit
describ
method
result
shown
tabl
compar
hsv
pfug
liver
applic
tit
level
measur
hplc
linear
regress
correl
hplc
nmr
p
fig
show
actual
nmr
trace
pgml
standard
b
liver
homogen
infect
mous
h
iv
inject
mgikg
tft
area
peak
correspond
fgg
liver
c
liver
homogen
cc
treat
mous
liver
homogen
uninfect
mous
h
iv
inject
mgkg
tft
specif
control
cba
mice
infect
murin
hepat
viru
coronaviru
contain
thymidin
kinas
shown
fig
increas
concentr
tft
liver
mhv
infect
mice
h
iv
inject
tft
compar
level
found
uninfect
mice
experi
contrast
infect
mice
titer
pfu
hsvg
liver
strikingli
elev
level
fig
infect
cbaj
mice
mhva
show
level
tft
rang
uninfect
mice
relationship
mhv
titer
tfi
level
observ
posit
control
cbaj
mice
infect
time
infect
mhva
infect
rang
pfuig
liver
show
high
level
tfi
liver
symbol
use
l
omhva
n
uninfect
significantli
higher
level
tfi
observ
liver
infect
mice
compar
uninfect
mice
mice
infect
mhv
mice
treat
ccl
effect
repeatedli
demonstr
correl
level
infect
sinc
blood
level
tit
among
infect
mice
similar
even
lower
uninfect
mice
ccl
treat
mice
seem
unlik
delay
excret
otherwis
alter
pharmacokinet
could
account
higher
level
tft
observ
infect
liver
nonspecif
accumul
due
hepat
damag
seem
unlik
well
view
result
mhv
ccl
hepat
tft
accumul
specif
due
phosphoryl
induc
thymidin
kinas
would
expect
find
mono
di
triphosphoryl
intermedi
liver
tissu
howev
phosphoryl
nucleosid
adenosin
triphosph
degrad
rapidli
correspond
nucleosid
cessat
blood
flow
hypoxia
measur
intermedi
imposs
unless
made
vivo
clous
snap
freez
tissu
liquid
n
follow
chemic
analysi
high
resolut
jlp
nmr
glonek
condit
hplc
measur
perform
phosphoryl
intermedi
would
detect
radioact
tft
avail
microscop
autoradiograph
correl
hsv
antigen
posit
cell
possibl
data
literatur
provid
support
hsv
specif
concentr
antivir
drug
hsv
infect
tissu
price
et
al
price
et
al
saito
et
al
saito
et
al
use
label
oarabinosyluracil
fmau
abl
show
specif
concentr
drug
optic
nerv
chiasm
rat
intraocular
inocul
howev
also
nonspecif
accumul
fmau
choroid
plexu
cell
line
ventricular
wall
biron
et
al
studi
label
acyclovir
shown
accumul
intracellularli
hsv
infect
cell
vitro
furman
follow
sc
inject
acyclovir
level
similar
hsv
infect
uninfect
tissu
studi
ie
liver
kidney
spleen
lung
blood
brain
price
et
al
also
unabl
demonstr
select
accumul
acyclovir
hsv
infect
tissu
vivo
seem
difficult
reconcil
lack
accumul
acyclovir
hsv
infect
tissu
observ
high
level
tft
liver
infect
mice
sinc
compound
phosphoryl
hsv
tk
accumul
tissu
cultur
recent
smee
et
al
show
acyclovir
accumul
form
phosphoryl
intermedi
hsv
infect
cell
vitro
also
rapidli
degrad
back
acyclovir
diffus
cell
smee
et
al
contrast
dhpg
also
accumul
similar
manner
hydrolyz
back
parent
compound
readili
thu
even
relat
drug
util
basic
step
mechan
action
behav
quit
differ
biolog
furthermor
use
iv
inject
tft
via
jugular
vein
would
result
extrem
high
blood
level
initi
rapid
fall
observ
ie
detect
drug
h
blood
gave
tft
ip
inject
unabl
demonstr
accumul
tft
liver
hsv
infect
mice
sinc
biron
et
al
use
sc
inject
sinc
plasma
level
remain
reason
elev
h
inject
possibl
depot
effect
sc
inject
togeth
propens
phosphoryl
acyclovir
rapidli
hydrolyz
back
parent
compound
respons
lack
accumul
anoth
differ
experi
biron
et
al
measur
drug
level
day
infect
drug
studi
carri
day
infect
possibl
relationship
drug
accumul
level
infect
chang
cours
infect
preliminari
observ
regard
discuss
nuclear
magnet
reson
spectroscopi
use
measur
level
f
sinc
essenti
tissu
background
level
fluorin
area
curv
could
directli
relat
standard
use
estim
tissu
level
tft
tft
level
low
kgg
tissu
readili
detect
even
dilut
use
requir
min
acquisit
time
albeit
high
field
strength
although
highest
field
strength
use
diagnost
human
f
nmr
surfac
coil
technolog
may
well
suffici
sensit
rang
field
strength
exampl
biospec
system
oper
mhz
use
investig
metabolit
fu
detect
limit
pmolig
mous
liver
mous
tumor
l
min
acquisit
time
manufactur
technic
inform
wolf
et
al
report
similar
studi
behavior
fu
human
liver
obtain
suitabl
spectra
min
field
transit
spectroscopi
surfac
coil
configur
requir
studi
live
organ
may
pose
problem
would
probabl
result
much
loss
sensit
one
interest
find
higher
level
tft
could
found
liver
infect
mice
day
well
day
follow
infect
viral
titer
quit
low
lo
g
liver
compar
mice
demonstr
tft
accumul
day
pfuig
liver
alt
level
blood
mice
day
hsv
infect
also
much
lower
compar
day
rang
iuiml
blood
data
avail
small
number
anim
sinc
hsv
induc
tk
maxim
produc
approxim
h
infect
kit
fong
releas
infecti
viru
possibl
earli
cours
infect
vivo
viru
spread
rapidli
infect
ever
increas
number
new
cell
higher
level
tk
present
rel
number
infecti
virion
result
greater
uptak
tft
per
infecti
unit
proof
tft
accumul
due
specif
induct
tk
would
requir
direct
measur
phosphoryl
tft
mutant
induc
tk
could
use
control
gener
less
virul
wild
type
hsv
coen
sinc
level
tft
achiev
depend
viral
titer
tk
neg
strain
would
replic
titer
equival
wild
type
vivo
result
interpret
summari
highli
elev
level
tft
observ
liver
infect
mice
compar
either
uninfect
mice
mice
infect
treat
mice
good
correl
tft
level
liver
tissu
titer
tissu
neither
alter
pharmacokinet
nonspecif
liver
damag
could
account
observ
drug
accumul
nmr
spectroscopi
sensit
detect
high
level
tft
readili
thu
offer
potenti
noninvas
method
diagnosi
viscer
hsv
infect
tft
readili
cross
blood
brain
barrier
methodolog
may
directli
applic
diagnosi
hsv
enceph
howev
viscer
infect
particularli
involv
liver
well
describ
immunocompromis
berglin
taylor
walker
elliott
holdsworth
well
nonimmunocompromis
patient
diaz
gomez
anura
connor
eron
manoux
joseph
de
berardini
addit
neonat
dissemin
infect
may
clinic
obviou
skin
vesicl
oral
ulcer
kerat
moedi
still
liver
involv
studi
tft
accumul
need
clinic
applic
test
